Astrana Health Inc (ASTH)

Return on equity (ROE)

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Net income (ttm) US$ in thousands 62,420 60,717 44,633 45,759 44,539 45,671 61,678 72,897 73,605 72,492 70,270 52,579 46,965 37,866 34,536 21,527 18,028 14,116 4,293 9,695
Total stockholders’ equity US$ in thousands 653,490 614,218 593,714 566,012 548,293 542,561 510,438 479,966 472,638 448,167 435,237 401,360 349,091 330,824 228,404 207,023 197,080 191,549 190,734 185,400
ROE 9.55% 9.89% 7.52% 8.08% 8.12% 8.42% 12.08% 15.19% 15.57% 16.18% 16.15% 13.10% 13.45% 11.45% 15.12% 10.40% 9.15% 7.37% 2.25% 5.23%

March 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $62,420K ÷ $653,490K
= 9.55%

Astrana Health Inc's return on equity (ROE) has shown fluctuations over the past 20 quarters. The ROE ranged from a low of 2.25% in the fourth quarter of 2019 to a high of 16.18% in the first quarter of 2022.

Overall, the company's ROE has been relatively stable, with a general upward trend from 2020 to 2022. However, there was a slight decline in ROE in the most recent quarter, dropping to 9.55%.

The ROE measures the company's ability to generate profits from its shareholders' equity, indicating how efficiently it is utilizing its capital. Astrana Health Inc's ROE figures suggest that the company has been able to deliver satisfactory returns to its shareholders over the analyzed period, albeit with some variability. Further analysis of the company's financial performance and operational efficiency would be needed to fully understand the factors driving these fluctuations in ROE.